Extended-Release Molindone (SPN-810) As Adjunctive Therapy in the Management of Impulsive Aggression in Children With ADHD Receiving Optimized Stimulant Monotherapy and Behavioral Therapy

New Research Poster Presentation 2.20
Extended-Release Molindone (SPN-810) As Adjunctive Therapy in the Management of Impulsive Aggression in Children With ADHD Receiving Optimized Stimulant Monotherapy and Behavioral Therapy

Thursday, October 29, 2015 10:00 AM

Scott T. Brittain, PhD, Supernus Pharmaceuticals, Inc., Rockville, MD

Jennifer D. Stocks, MS, Supernus Pharmaceuticals, Inc., Rockville, MD

Janet A. Johnson, PhD, Supernus Pharmaceuticals, Inc., Rockville, MD

Tesfaye Liranso, PhD, Supernus Pharmaceuticals, Inc., Rockville, MD

Robert L. Findling, MD, MBA, The Johns Hopkins University, Baltimore, MD